tm logo
PASATRU
ADVERTISED

on 08 Nov 2024

Last Applicant/ Owned by

REGENERON PHARMACEUTICALS INC.

777 Old Saw Mill River RoadTarrytown, NY 10591

US

Serial Number

2021989 filed on 09th Apr 2020

Registration Number

TMA1267894 registered on 08th Nov 2024

Registration expiry Date

08th Nov 2034

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

PASATRU

Trademark usage description

pharmaceutical preparations for treatment or prevention of ebola virus infections allergy medications; anti-inflammatory pharmaceutical preparations; Read More

Classification Information


Class [005]
Allergy medications; anti-inflammatory pharmaceutical preparations; anti-viral agents; antiallergic medicines; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of muscular atrophy; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations namely, anti-inflammatories;


Classification kind code

11

Mark Details


Serial Number

2021989

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 08th Nov 2024
Registration Pending
Submitted for opposition 67
on 27th Sep 2024
Agent Name Changed
Submitted for opposition 42
on 21st Aug 2024
Advertised
Submitted for opposition 27
on 29th Jul 2024
Approval Notice Sent
Submitted for opposition 26
on 29th Jul 2024
Approved
Submitted for opposition 22
on 09th Jul 2024
Search Recorded
Submitted for opposition 287
on 30th Mar 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 09th Apr 2020
Filed
Submitted for opposition 1
on 09th Apr 2020
Created
Submitted for opposition 31
on 09th Apr 2020
Formalized